Non-NAD-like PARP1 inhibitor enhanced synthetic lethal effect of NAD-like PARP inhibitors against BRCA1-deficient leukemia

Margaret Nieborowska-Skorska, Silvia Maifrede, Min Ye, Monika M. Toma, Elizabeth Hewlett, John Gordon, Bac Viet Le, Tomasz Sliwinski, Huaqing Zhao, Katarzyna Piwocka, Peter Valent, Alexei Tulin, Wayne Childers, Tomasz Skorski

Research output: Contribution to journalLetterpeer-review

13 Scopus citations
Original languageEnglish
Pages (from-to)1098-1101
Number of pages4
JournalLeukemia and Lymphoma
Volume60
Issue number4
DOIs
StatePublished - Mar 21 2019

Keywords

  • BRCA1 Protein/deficiency
  • Cell Line, Tumor
  • Cell Survival/drug effects
  • Drug Synergism
  • Humans
  • Leukemia/genetics
  • Phthalazines/pharmacology
  • Piperazines/pharmacology
  • Poly(ADP-ribose) Polymerase Inhibitors/chemistry
  • Synthetic Lethal Mutations/drug effects

Cite this